NDAOPHTHALMICOINTMENT
Approved
Jun 1958
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 9h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
OPHTHOCORT is a fixed-combination ophthalmic ointment containing chloramphenicol (broad-spectrum antibiotic), hydrocortisone acetate (corticosteroid), and polymyxin B sulfate (antibiotic) approved in 1958. It treats bacterial eye infections and inflammatory eye conditions by combining antimicrobial and anti-inflammatory activity. The triple-agent formulation provides rapid symptom relief in acute bacterial conjunctivitis and related ocular infections.
LOE Approaching
Late-stage product with limited commercial momentum; brand teams are likely focused on defending market share against modern alternatives rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
OPHTHOCORT offers limited career growth opportunities given its late-stage lifecycle and declining market relevance. Positions are primarily defensive, focused on maintaining compliance, managing SKU rationalization, and supporting routine operational maintenance rather than strategic growth or innovation.
Brand ManagerField Sales Representative
Worked on OPHTHOCORT at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.